HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miao Wang Selected Research

yinchen

6/2021Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis.
5/2021Rapid characterization of the chemical constituents of Yinchen Wuling Powder by UPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry.
1/2021Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miao Wang Research Topics

Disease

117Neoplasms (Cancer)
07/2022 - 05/2003
29Inflammation (Inflammations)
12/2022 - 01/2005
27Neoplasm Metastasis (Metastasis)
01/2022 - 07/2006
24Infections
12/2022 - 06/2005
21Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2005
19Atherosclerosis
02/2021 - 01/2005
18Hypertension (High Blood Pressure)
01/2022 - 06/2010
17Breast Neoplasms (Breast Cancer)
01/2021 - 01/2008
16Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2013
15Insulin Resistance
11/2019 - 11/2003
14Carcinogenesis
01/2022 - 12/2008
13Coronary Disease (Coronary Heart Disease)
01/2022 - 10/2008
12Urinary Bladder Neoplasms (Bladder Cancer)
02/2021 - 02/2014
11Prostatic Neoplasms (Prostate Cancer)
07/2022 - 12/2008
11Fibrosis (Cirrhosis)
01/2022 - 07/2013
10Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2008
10Non-alcoholic Fatty Liver Disease
01/2022 - 09/2011
9COVID-19
12/2022 - 10/2020
9Obesity
01/2022 - 01/2013
9Critical Illness (Critically Ill)
08/2015 - 01/2010
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 06/2008
7Pain (Aches)
07/2022 - 07/2010
7Lung Neoplasms (Lung Cancer)
01/2022 - 07/2006
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 05/2008
7Stroke (Strokes)
01/2020 - 05/2006
6Hyperplasia
05/2022 - 02/2011
6Parkinson Disease (Parkinson's Disease)
01/2022 - 12/2013
6Carcinoma (Carcinomatosis)
01/2022 - 11/2007
6Hypoxia (Hypoxemia)
01/2021 - 10/2016
5Wounds and Injuries (Trauma)
11/2022 - 01/2020
5Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2013
5Heart Failure
01/2022 - 12/2012
5Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 10/2014
5Renal Cell Carcinoma (Grawitz Tumor)
04/2021 - 02/2015
5Carotid Artery Diseases
07/2020 - 05/2012
5Myocardial Infarction
01/2020 - 05/2006
5Thrombosis (Thrombus)
01/2020 - 09/2015
4Mitochondrial Diseases (Mitochondrial Disease)
12/2022 - 04/2014
4ST Elevation Myocardial Infarction
01/2022 - 01/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2014
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 05/2015
4Virus Diseases (Viral Diseases)
12/2021 - 01/2019
4Rheumatoid Arthritis
07/2021 - 02/2020
4Hepatitis
06/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2008
23Pharmaceutical PreparationsIBA
05/2022 - 04/2005
23LipidsIBA
01/2022 - 03/2013
18Biomarkers (Surrogate Marker)IBA
04/2022 - 05/2003
14MicroRNAs (MicroRNA)IBA
07/2022 - 06/2009
11Glucose (Dextrose)FDA LinkGeneric
11/2022 - 07/2008
11Insulin (Novolin)FDA Link
11/2022 - 02/2007
11Long Noncoding RNAIBA
01/2022 - 01/2015
11Biological ProductsIBA
01/2022 - 06/2011
11oxidized low density lipoproteinIBA
10/2021 - 06/2010
11CholesterolIBA
07/2020 - 11/2013
10Triglycerides (Triacylglycerol)IBA
03/2022 - 10/2008
10Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 09/2009
10EnzymesIBA
11/2021 - 09/2006
8Therapeutic UsesIBA
05/2022 - 12/2008
8Messenger RNA (mRNA)IBA
11/2021 - 11/2007
8LDL CholesterolIBA
10/2021 - 07/2010
8RNA (Ribonucleic Acid)IBA
01/2021 - 03/2010
8Peptides (Polypeptides)IBA
10/2020 - 06/2008
7Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2021 - 11/2010
7Circular RNAIBA
01/2021 - 01/2017
6C-Reactive ProteinIBA
07/2022 - 01/2011
6CytokinesIBA
02/2022 - 01/2018
6HDL CholesterolIBA
10/2021 - 10/2010
6Lysine (L-Lysine)FDA Link
01/2021 - 03/2018
6Angiotensin IIIBA
01/2021 - 03/2008
6ProstaglandinsIBA
01/2020 - 01/2005
5AntibodiesIBA
12/2022 - 01/2017
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
5Oxygen (Dioxygen)IBA
01/2022 - 06/2005
5Indicators and Reagents (Reagents)IBA
11/2020 - 06/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 02/2005
5Dinoprostone (PGE2)FDA Link
01/2020 - 01/2005
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2020 - 01/2005
5Endoplasmic Reticulum Chaperone BiPIBA
12/2010 - 01/2008
4Uric Acid (Urate)IBA
12/2022 - 10/2007
4AntigensIBA
12/2022 - 10/2008
4VaccinesIBA
12/2022 - 06/2009
4InterferonsIBA
01/2022 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2013
4B7-H1 AntigenIBA
01/2022 - 03/2019
4ApolipoproteinsIBA
11/2021 - 01/2005
4LipopolysaccharidesIBA
10/2021 - 07/2006
4Urea (Carbamide)FDA LinkGeneric
06/2021 - 01/2017
4Transcription Factors (Transcription Factor)IBA
02/2021 - 03/2013

Therapy/Procedure

42Therapeutics
09/2022 - 06/2008
13Immunotherapy
01/2022 - 01/2017
11Drug Therapy (Chemotherapy)
03/2022 - 07/2006
9Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2021 - 10/2009
7Radiotherapy
01/2022 - 07/2006
7Percutaneous Coronary Intervention
03/2020 - 01/2014
5Photothermal Therapy
01/2022 - 12/2017
5Enteral Nutrition (Feeding, Tube)
08/2015 - 03/2011
4Precision Medicine
01/2022 - 01/2018
4Prostatectomy (Retropubic Prostatectomy)
05/2021 - 11/2018